MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
Reason
July 2009
Jacob Sullum
Drug Control Begets Gun Control The violence in Mexico is caused by prohibition, not firearms. mark for My Articles similar articles
BusinessWeek
August 26, 2010
Jens Erik Gould
In Mexico, a Call to Legalize Drugs Mexico is publicly debating the idea of legalizing drug use to weaken the cartels. It would be an effective step only if the U.S. did the same. mark for My Articles similar articles
IndustryWeek
January 11, 2012
Managing Security and Violence in Mexico Drug-related violence has U.S. manufacturers reviewing their strategies for operating in Mexico. mark for My Articles similar articles
IDB America
November 2003
Alexandra Russell-Bitting
Rx for democracy A new study examines the health of Latin America's democracies, and prescribes a strong dose of political reform. mark for My Articles similar articles
The Motley Fool
May 26, 2011
Brian Orelli
Congress Sets Bad Precedent With AVANIR What happened to free markets? mark for My Articles similar articles
The Motley Fool
May 21, 2010
Brian Orelli
And You Thought Biotech Was High-Risk, High-Reward Large clinical trials make cardiovascular drugs risky, but the rewards are there, too. mark for My Articles similar articles
The Motley Fool
December 31, 2010
Brian Orelli
2010 FDA Approvals and a Look Ahead Recent history can help us handicap FDA decisions. mark for My Articles similar articles
The Motley Fool
May 31, 2011
Brian Orelli
Profit From This Growing Drug Trend Cancer drugs press on. mark for My Articles similar articles
IDB America
February 2003
Charo Quesada
The case for cautious optimism Brazil's outgoing president argues that Latin American development is advancing in the midst of crisis. mark for My Articles similar articles
IDB America
May 2002
Roger Hamilton
May I persuade you to be honest? Brazil finds an innovative way to ensure that senior civil servants are not tempted to abuse their power mark for My Articles similar articles
Commercial Investment Real Estate
Mar/Apr 2012
Oscar J. Franck Terrazas
Mexico or Brazil? Investors may be surprised at the comparison of these two countries. mark for My Articles similar articles
The Motley Fool
February 25, 2010
Brian Orelli
An Untouched Market Waiting to Be Captured Unfilled prescriptions are a potential boon to drug companies. mark for My Articles similar articles
Reason
June 2005
Toby Muse
Legalize Now! War-weary Colombia--and its Conservative Party--consider ending the drug war. mark for My Articles similar articles
Salon.com
February 22, 2000
Michael Massing
The elephant in the room Presidential candidates are silent on the failure of the U.S. war on drugs. mark for My Articles similar articles
Chemistry World
November 2010
Column: In the Pipeline Should drug companies focus on big markets and the blockbuster dream? mark for My Articles similar articles
The Motley Fool
July 30, 2010
Brian Orelli
A Faster Pathway to Drug Approvals A thinktank called the Pacific Research Institute has proposed letting drugs approved by the European Medicines Authority onto the market in the U.S. before the Food and Drug Administration has approved the drugs. mark for My Articles similar articles
The Motley Fool
July 30, 2010
Brian Orelli
3 Development-Stage Drugmakers Worth Watching A basket of potential drugs in just one company. mark for My Articles similar articles
The Motley Fool
September 30, 2010
Brian Orelli
Avoid This Multibillion-Dollar Market It's just too crowded, but there's no doubt that psychiatric drugs are big business for some drugmakers. mark for My Articles similar articles
The Motley Fool
September 28, 2010
Brian Orelli
Don't Get Stuck! Invest in Needle-Free Drugs Here's how to make some money off society's general disdain for needles through next-generation drugs. mark for My Articles similar articles
The Motley Fool
February 16, 2010
Brian Orelli
For Blockbuster Cancer Drugs, Approvals Are the Easy Part Don't get too excited. As an investor, you can lower your risk by investing in cancer drug companies after a clinical trial success but before an FDA approval, but you'll also reduce your reward. mark for My Articles similar articles
The Motley Fool
February 28, 2011
Brian Orelli
Rare Diseases, Big Opportunity "Orphan" drugs to keep your eye on. mark for My Articles similar articles
On Wall Street
October 1, 2010
Milton Ezrati
Despite Violence, Mexico's Economy Begins to Improve Despite terrible problems, once the U.S. recovery begins to create jobs, remittances from Mexican nationals working north of the border will begin to add marginal momentum to Mexico's economic growth and, hence, to its market prospects. mark for My Articles similar articles
AskMen.com
June 29, 2003
Bernie Alexander
Worldwide Marijuana Sanctions This article explores the way the justice systems of different countries, such as the Netherlands, Mexico and Thailand, deal with crimes involving marijuana mark for My Articles similar articles
The Motley Fool
March 31, 2011
Brian Orelli
Hepatitis C Drugs Heat Up The current hepatitis C drugs stink. Who's ahead in the race to find new ones? mark for My Articles similar articles
IDB America
June 2004
Mayra Buvinic
Against the Odds Bogota proves that violence prevention can work, even in the toughest settings. mark for My Articles similar articles
The Motley Fool
January 29, 2010
Brian Orelli
How to Make Billions of Dollars Without Really Trying Lackluster Alzheimer's drugs have been doing it for years. mark for My Articles similar articles
Chemistry World
March 2011
Column: In the pipeline Drug discovery is an inherently risky business. Derek Lowe tries to balance some of the risk equations mark for My Articles similar articles
Chemistry World
November 18, 2010
Ned Stafford
New drug pricing rules in Germany The law was approved on 11 November and will take effect from 1 January as part of an effort to rein in exploding costs for Germany's massive public health insurance system. mark for My Articles similar articles
The Motley Fool
November 30, 2010
Brian Orelli
A Witty Response to Pharma's R&D Dilemma According to GlaxoSmithKline CEO Andrew Witty, the pharmaceutical industry is a mess. That's the basic gist of his opinion piece in The Economist. mark for My Articles similar articles
IDB America
February 2002
Charo Quesada
Leadership, consensus, and technology With broad support from society, Brazil is improving the quality of life of HIV carriers... mark for My Articles similar articles
Reason
February 2003
Letters Gun Control Twists... True Patriots... mark for My Articles similar articles
Salon.com
August 28, 2000
Ana Arana
War on drugs 1, human rights 0 On the eve of President Clinton's trip to Colombia, critics say Washington cares more about its war on drugs than human rights. mark for My Articles similar articles
Chemistry World
June 26, 2013
Emma Stoye
UN report warns of global rise in legal highs The latest World Drug Report from the United Nations Office on Drugs and Crime says governments around the world are struggling to cope with a growing number of legal party drugs. mark for My Articles similar articles
AskMen.com The War On The War On Drugs Mexico enacted a controversial law Thursday decriminalizing possession of small amounts of marijuana, cocaine, heroin and other drugs while encouraging free government treatment for drug dependency. mark for My Articles similar articles
BusinessWeek
May 10, 2004
Geri Smith
Democracy On The Ropes With corruption and economic woes rising, Latin America is disillusioned with democracy. mark for My Articles similar articles
BusinessWeek
July 5, 2004
Where To Dig Up Latin Gems How should investors play Latin America, given an impending rise in U.S. interest rates and a projected slowdown in commodities demand from Asia? mark for My Articles similar articles
The Motley Fool
August 26, 2010
Tim Hanson
Beware of Mexico Why investors should tread carefully when it comes to this emerging market on the U.S. border. mark for My Articles similar articles
Managed Care
October 2007
The Formulary Files Retirees stop taking drugs when annual benefit runs out. mark for My Articles similar articles
The Motley Fool
March 31, 2011
Brian Orelli
Drug Warning Labels: The Good, Bad, and Ugly Once a drug is approved, investors can't fall asleep and ignore FDA announcements about drugs. They come in different varieties, but warnings tend to be of the bad and ugly variety more often than the good. mark for My Articles similar articles
Investment Advisor
March 2007
Kathleen M. McBride
Native Speaker Gonzalo Pangaro, portfolio manager of the $2.3 billion T. Rowe Price Latin America Fund, is fluent in the languages and politics of Latin America and in portfolio construction. mark for My Articles similar articles
Managed Care
March 2008
Drug Caps Lower Spending, but .... These policies tend to make consumers shoulder some of the cost of prescriptions and the cost could be a barrier to medication adherence. mark for My Articles similar articles
Pharmaceutical Executive
August 1, 2012
Country Report: Mexico Jim O'Neill, chief economist at Goldman Sachs declared that by 2020 Mexico would be the seventh largest economy in the world, surpassing both India and Russia. The Mexican pharmaceutical industry has seen some significant changes over the last four years. mark for My Articles similar articles
The Motley Fool
August 26, 2010
Brian Orelli
Drug Prices Up, but Don't Read Too Much Into It AARP is out with its annual report on the cost of medications, and it's more of the same: bad news if you're a consumer, but good news if you're invested in drugmakers. mark for My Articles similar articles
The Motley Fool
January 26, 2011
Brian Orelli
Health-Care Reform Lives: Here's Where to Invest State of the Union turned investment thesis regarding health insurance companies. mark for My Articles similar articles
CRM
December 20, 2004
Coreen Bailor
The Next CRM Hot Spot? Latin American companies add flavor to their services, helping to nurture their customer relationships and maximize sales opportunities. mark for My Articles similar articles
Entrepreneur
March 2006
Dian Vujovich
Some Like it Hot Spice up your portfolio with a Latin American fund. But do it in small doses. mark for My Articles similar articles
ifeminists
April 14, 2009
Carey Roberts
Abuse Excuse: How Liberalism Keeps Women in their Place Liberals have become the unapologetic predators of women, gleefully playing on their fears and psychological vulnerabilities, all in the name of curbing domestic violence. mark for My Articles similar articles
IDB America
October 2004
Carlo Binetti
A Political Agenda Against Inequality In the last two decades, Latin America has been weighed down by the bitter paradox of trying to advance democracy even as poverty grows more extreme. Meanwhile, in the political arena, globalization has imposed new demands on the State. mark for My Articles similar articles
BusinessWeek
September 27, 2004
A Mexico-Japan Trade Deal After six years in the making, Mexico and Japan are finally set to sign a Free Trade Agreement covering most industrial products along with certain agricultural goods -- only the second such deal for Japan. mark for My Articles similar articles
The Motley Fool
January 28, 2010
Brian Orelli
How to Make a Billion Bucks in Biotech Drug companies and investors alike have to balance the risk and reward. mark for My Articles similar articles